Published in Transplantation on June 15, 2002
Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood (2007) 2.37
FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol (2007) 0.84
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res (2009) 3.39
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology (2007) 3.18
2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA (2010) 3.05
Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses. Influenza Other Respir Viruses (2009) 2.75
Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol (2009) 2.59
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol (2009) 2.30
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology (2006) 2.26
Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology (2005) 2.02
Living donor liver transplantation--adult donor outcomes: a systematic review. Liver Transpl (2006) 1.97
Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology (2009) 1.84
Steatosis: co-factor in other liver diseases. Hepatology (2005) 1.76
Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A (2010) 1.63
Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis (2010) 1.61
Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging (2008) 1.56
Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med (2011) 1.53
Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study. BMJ (2010) 1.52
The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection. J Exp Med (2002) 1.48
Toward a broadly protective influenza vaccine. J Clin Invest (2008) 1.40
Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc Natl Acad Sci U S A (2003) 1.39
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol Cell Biol (2009) 1.34
In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol (2003) 1.29
IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation. J Immunol (2005) 1.26
Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study. J Infect Dis (2010) 1.26
GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology (2010) 1.25
Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology (2004) 1.25
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology (2014) 1.24
Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model. PLoS Pathog (2013) 1.20
Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology (2005) 1.17
Progressive differentiation and commitment of CD8+ T cells to a poorly cytolytic CD8low phenotype in the presence of IL-4. J Immunol (2005) 1.15
Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol (2003) 1.13
Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transpl (2003) 1.11
A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses. Antiviral Res (2011) 1.08
Obesity management in liver clinics: translation of research into clinical practice. J Gastroenterol Hepatol (2007) 1.07
A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression. J Immunol (2002) 1.05
Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-alpha and cytochrome P450 2E1. J Gastroenterol Hepatol (2003) 1.05
Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol (2005) 1.04
Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C. Hepatology (2008) 1.04
Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides. Nat Commun (2013) 1.00
Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region. Western Pac Surveill Response J (2013) 0.99
Detection of evolutionarily distinct avian influenza a viruses in antarctica. MBio (2014) 0.98
Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. BMC Infect Dis (2010) 0.98
Pandemic (H1N1) 2009 risk for frontline health care workers. Emerg Infect Dis (2011) 0.97
Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus? J Biol (2009) 0.96
Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient. Influenza Other Respir Viruses (2013) 0.96
Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology (2011) 0.95
Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore. Influenza Other Respir Viruses (2013) 0.93
Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009. Emerg Infect Dis (2011) 0.93
IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response. J Immunol (2010) 0.93
Influenza antiviral resistance in the Asia-Pacific region during 2011. Antiviral Res (2012) 0.93
Interaction of non-alcoholic fatty liver disease with other liver diseases. Best Pract Res Clin Gastroenterol (2002) 0.92
Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis. J Hepatol (2008) 0.92
The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int (2012) 0.92
The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers. J Immunol Methods (2002) 0.91
Systematic review of the impact of volume of oesophagectomy on patient outcome. ANZ J Surg (2010) 0.90
Virus-specific CD8+ T lymphocytes within the normal human liver. Eur J Immunol (2004) 0.89
Profiling the CD8low phenotype, an alternative career choice for CD8 T cells during primary differentiation. Immunol Cell Biol (2004) 0.88
Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells. Proc Natl Acad Sci U S A (2008) 0.87
Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease. Ann Intern Med (2005) 0.87
Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C. Liver Int (2012) 0.86
Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. Dig Dis (2010) 0.86
Hepatic progenitor cell-mediated regeneration and fibrosis: chicken or egg? Hepatology (2009) 0.86
Centralization and the relationship between volume and outcome in knee arthroplasty procedures. ANZ J Surg (2010) 0.85
Measurement and stability of FTY720 in human whole blood by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.85
Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.85
Peramivir and laninamivir susceptibility of circulating influenza A and B viruses. Influenza Other Respir Viruses (2014) 0.84
Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clin Liver Dis (2007) 0.84
Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry. Clin Chem (2005) 0.84
Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand. HPB (Oxford) (2009) 0.84
Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells. Cancer Res (2006) 0.84
The use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B viruses. J Clin Virol (2013) 0.83
The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today (2003) 0.83
Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C. Psychosomatics (2004) 0.83
CD4+ T cells limit the damage in influenza. Nat Med (2012) 0.82
Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy. Mol Diagn Ther (2008) 0.82
Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study. Influenza Other Respir Viruses (2010) 0.82
Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia. Influenza Other Respir Viruses (2013) 0.82
Cold storage preservation and warm ischaemic injury to isolated arterial segments: endothelial cell injury. Am J Transplant (2002) 0.82